000 | 01169 a2200313 4500 | ||
---|---|---|---|
005 | 20250515073603.0 | ||
264 | 0 | _c20070710 | |
008 | 200707s 0 0 eng d | ||
022 | _a1533-4406 | ||
024 | 7 |
_a10.1056/NEJMcibr072412 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWilliams, David A | |
245 | 0 | 0 |
_aA new mechanism of leukemia drug resistance? _h[electronic resource] |
260 |
_bThe New England journal of medicine _cJul 2007 |
||
300 |
_a77-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aAsparaginase _xtherapeutic use |
650 | 0 | 4 |
_aAsparagine _xdrug effects |
650 | 0 | 4 |
_aAspartate-Ammonia Ligase _xbiosynthesis |
650 | 0 | 4 |
_aBone Marrow Cells _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMesenchymal Stem Cells _xmetabolism |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
773 | 0 |
_tThe New England journal of medicine _gvol. 357 _gno. 1 _gp. 77-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMcibr072412 _zAvailable from publisher's website |
999 |
_c17147192 _d17147192 |